DOCSLIB.ORG

Structure Determination and Biochemical Characterization of Novel Human Ubiquitin-Like Domains

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

STRUCTURE DETERMINATION AND BIOCHEMICAL CHARACTERIZATION OF NOVEL HUMAN UBIQUITIN-LIKE DOMAINS. by Ryan Steven Doherty A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Graduate Department of Medical Biophysics University of Toronto © Copyright by Ryan Steven Doherty 2015 STRUCTURE DETERMINATION AND BIOCHEMICAL CHARACTERIZATION OF NOVEL HUMAN UBIQUITIN-LIKE DOMAINS Ryan Steven Doherty Doctor of Philosophy Department of Medical Biophysics University of Toronto 2015 Abstract The ubiquitin fold acts as a signaling modulator associated with regulating, trafficking, and degrading proteins. The human genome encodes 398 ubiquitin-like domains (UBLs), of which a couple dozen may act as covalent modifiers. Ubiquitin and ubiquitin-like domains have been implicated in a number of malignancies, neuromuscular disorders, neurodegenerative disorders and other human illnesses. Identifying the structural effects of sequence variations between different ubiquitin-like homologues will provide insight into their varied functional pathways, since the role of ubiquitin-like modifiers is typically mediated by protein-protein interactions. Structure determination and analyses of ubiquitin-like homologues facilitates residue mapping and comparative analysis of protein-protein interaction sites, which provide insight into the many roles that ubiquitin-like homologues play in cellular processes. The aim of this thesis was to develop a framework through which complete structural coverage of all human ubiquitin-like domains could be achieved. To accomplish this, I defined the human ubiquitin-like fold family, identified ubiquitin- like domain constructs amenable for NMR structure determination, solved two structures ii (NFATc2IP & ubiquilin-1) and characterized associated binding partners, and created a data resource for human ubiquitin-like domains that enables clustering and associating protein structures with physicochemical features and cellular function. I also collaborated with the North- East Structural Genomics consortium (NESG) and the Structural Genomics Consortium (SGC), through which the molecular structures of 17 ubiquitin-like domains were determined using nuclear magnetic resonance (NMR) experiments and X-ray crystallography. Comparative analysis of structurally characterized ubiquitin-like folds revealed potential interaction partners with regions similar to known ubiquitin and SUMO interacting domains. Potential interaction partners for NFATC2IP and ubiquilin-1 were validated experimentally using NMR titration experiments. Comparative analysis of structural features of all ubiquitin-like homologues facilitates further studies into the mechanisms of the ubiquitylation system, predicted protein- protein interactions, and the identification of functional pathways associated with uncharacterized ubiquitin-like domains. iii Acknowledgements I would like to thank my supervisor Cheryl Arrowsmith for her ongoing support, advice and mentorship over the years. I also appreciate the guidance and knowledge shared by my supervisory committee members: Sirano Dhe-Paganon, Brian Raught, Jane McGlade, and Zhaolei Zhang. I would also like to recognize the efforts and support from members of the Arrowsmith lab, past and present, especially Adelinda Yee, Shili Duan, Scott Houliston, Sasha Lemak, Aleks Gutmanas, Christophe Fares, Yi Sheng, Lilia Kaustov, Bin Wu, Seth Chitayat, Sampath Srisailam, Murthy Karra, Jonathan Lukin, Natalie Nady, Jack Liao, Rob Laister, Melissa Ho, Tony Semesi, and Maite Garcia. This thesis would not have been possible without collaborations. For this reason, I would like to thank Gaetano Montelione, John Everett, Mani Ravichandran, Yufeng Tong, Masoud Vedadi, David Yim and Raymond Hui for their time, resources, feedback and help in key aspects of this project. I would also like to thank members of various University of Toronto communities who have encouraged, supported and worked alongside me throughout this endeavor: Medical Biophysics Graduate Student Association, 89 Chestnut Residence, Massey College, Massey Grand Rounds, and Impact Centre. Finally, I thank my family and friends for their patience, love and understanding. It is to you that I dedicate this thesis. iv Table of Contents Abstract ii Acknowledgements iv Table of Contents v List of Tables x List of Figures xi List of Appendices xiii List of Abbreviations xiv Chapter 1 - Introduction 1 1.1 Overview 1 1.2 Biological Significance of ubiquitin & ubiquitin-like modifiers 2 1.3 Protein Modification & ubiquitin 2 1.4 The ubiquitin Fold 3 1.5 Ubiquitin-like domains (UBLs) 4 1.6 Ubiquitin-like modifiers (UBM) 6 1.7 Ubiquitin-like structural domains 9 1.8 Ubiquitin Conjugation Cascade 9 1.9 Ubiquitin-binding domains & interactions 11 1.9.1 Ubiquitin Interacting Motif (UIM) 11 1.9.2 Coupling of Ubiquitin conjugation to Endoplasmic Reticulum 12 Degradation (CUE) 1.9.3 Ubiquitin-Associated Domain (UBA) 12 1.9.4 Ubiquitin Conjugating Enzyme Variant (UEV) 12 1.9.5 Npl4 Zing Finger Motif (NZF) 13 1.9.6 GGA And Tom1 Domain (GAT) 13 1.9.7 Other Ubiquitin Binding Domains 13 1.9.8 SUMO Interacting Motif (SIM) 13 v Table of Contents (continued) 1.9.9 Diversity among Ubiquitin-Binding Domains 14 1.10 Thesis Overview 15 1.10.1 Identify and obtain near-complete structural coverage of all 15 human ubiquitin-like domains. 1.10.2 Exploring NFATc2IP:NFATc2 & ubiquilin-1:PIN2 15 protein-protein interactions Chapter 2 - The Ubiquitin Fold: Leveraging structural genomics 17 2.1 Summary 18 2.2 Introduction 18 2.3 Methods 21 2.3.1 Identifying human ubiquitin-like domains 21 2.3.2 Validating putative human ubiquitin-like domains 22 2.3.3 Target selection 24 2.3.4 Construct design 25 2.3.5 Sample preparation 26 2.3.6 1H15N-HSQC screening of ubiquitin-like domains 26 2.4 Results & Discussion 27 2.4.1 Identifying unannotated human ubiquitin-like domains 27 2.4.2 Small-Scale Screening 29 2.4.3 Screening by 1H15N-HSQC 29 2.4.4 Structural Coverage - Completing the UBL Phylogenetic Tree 31 2.5 Conclusion 36 Chapter 3 - Solution NMR structure determination of human ubiquitin-like domains 37 in NFATc2IP & ubiquilin-1 3.1 Introduction 38 3.1.1 NFATc2IP 38 3.1.2 Ubiquilin-1 39 vi Table of Contents (continued) 3.1.3 Ubiquitin-like Fold 39 3.2 Experimental Procedures 40 3.2.1 NFATc2IP UBL domain NMR structure determination 40 3.2. 2 Ubiquilin-1 UBL domain NMR structure determination 41 3.2. 3 Comparative analysis of ubiquilin-1, NFATc2IP, 44 ubiquitin & SUMO2 3.2. 4 Protein-protein interaction partner identification 46 3.2. 5 Binding interface analysis 46 3.3 Results & Discussion 47 3.3.1 Structure determination 47 3.3.2 Comparative analysis of ubiquilin-1, NFATc2IP & similar 52 ubiquitin-like modifiers 3.3.2.1 Similar canonical ubiquitin-like modifiers: ubiquitin & SUMO-2 53 3.3.2.2 Structural comparison between ubiquilin-1 & NFATc2IP 53 3.3.2.3 Structural comparison between ubiquilin-1 & ubiquitin 55 3.3.2.4 Structural comparison between NFATc2IP & SUMO2 57 3.3.2.5 Structural differences between NFATc2IP_2nd & SUMO2 58 3.3.3 From Structure to Function: Exploring Protein-Protein Interactions 59 involving ubiquitin-like domains 3.3.3.1 The ubiquitin-Interacting Motif interaction interface 59 3.3.3.2 Putative UIM Interaction Interface: Conserved Amino Acids 62 3.3.3.3 Putative UIM Interaction Interface: Similar Electrostatic 63 Potential Distribution 3.3.3.4 Surveying Known UIM-Binding Partners 64 3.3.3.5 PIN1 – Peptidyl-Prolyl cis/trans Isomerase 67 3.3.3.6 Identifying a putative UIM in PIN1 67 3.3.3.7 Ubiquilin-1 & PIN1 NMR Titration 68 vii Table of Contents (continued) 3.3.3.8 Analysis of the ubiquilin-1 & PIN1 interface 70 3.3.4 Binding-Partner Driven - Structural analysis of the 71 SUMO-Interacting Motif binding interface 3.3.4.1 NFATc2IP Binding Partners 71 3.3.5 SUMO-Interacting Motif 72 3.3.5.1 Identifying putative SIMs in NFATc2 72 3.3.6 NFATc2IP:NFATc2 NMR titration 74 3.3.6.1 Analysis of the NFATc2IP:NFATc2 interface 75 3.4 Conclusion 77 Chapter 4 - Exploring UBLs & UBL-Interaction Motifs: Computational & 78 Experimental analysis of ubiquilin, NFATc2IP, UIMs and SIMs. 4.1 Introduction 79 4.1.1 Database & comparative analysis 79 4.1.1.1 Similarities & differences between model family members 80 4.1.1.2 Common defining features for each modelling family 80 4.2 Experimental Procedures 81 4.2.1 UBL Database Development 81 4.2.2 Relating 17 structurally determined UBLs to nearest neighbours 82 and model families 4.2.3 Secondary structure prediction & analysis 83 4.2.4 Relating structural features to functional pathways 83 4.3 Results 84 4.3.1 Structurally characterized ubiquitin-like domains 84 4.3.2 Nearest-neighbours of ubiquitin-like domains 85 4.3.3 Nearest-neighbours of structurally characterized UBMs 86 4.3.4 Grouping UBLs based on biological processes and 89 molecular function viii Table of Contents (continued) 4.3.5 Grouping UBLs based on medical significance 91 4.3.5.1 Cellular localization 92 4.3.6 Grouping UBLs based on cell localization 93 4.4 Conclusion 95 Chapter 5 - Conclusion and Future Directions 96 5.1 Conclusions 96 5.2 Future Directions 97 5.2.1 Ubiquitin-like domain fold, NFATc2IP & ubiquilins 97 5.2.2 Ubiquitin-like domain structural genomics 98 5.2.3 Protein Domain family analyses 98 5.3 Concluding remarks 98 Chapter 6 - References 99 ix List of Tables Table 1.1: List of 18 annotated ubiquitin-like modifiers, and associated enzymatic 8 complement, substrates and functional pathways. Table 1.2: Protein-protein interaction modes structurally characterized with 14 experimentally determined binding affinities between UBLs and binding partners. Table 2.1: Summary of small-scale expression screening of human ubiquitin-like 29 domains structurally characterized and deposited in the PDB as part of this thesis. Table 2.2: Summary of 1H15N-HSQC screening results for human ubiquitin-like 30 domains. 10 ubiquitin-like domains were solved by NMR (red), and 7 ubiquitin-like domains were solved by X-ray crystallography (blue).
Recommended publications
  • Molecular Cytogenetic Analysis for TFE3 Rearrangement In

    Molecular Cytogenetic Analysis for TFE3 Rearrangement In

    Modern Pathology (2014) 27, 113–127 & 2014 USCAP, Inc. All rights reserved 0893-3952/14 $32.00 113 Molecular cytogenetic analysis for TFE3 rearrangement in Xp11.2 renal cell carcinoma and alveolar soft part sarcoma: validation and clinical experience with 75 cases Jennelle C Hodge, Kathryn E Pearce, Xiaoke Wang, Anne E Wiktor, Andre M Oliveira and Patricia T Greipp Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA Renal cell carcinoma with TFE3 rearrangement at Xp11.2 is a distinct subtype manifesting an indolent clinical course in children, with recent reports suggesting a more aggressive entity in adults. This subtype is morphologically heterogeneous and can be misclassified as clear cell or papillary renal cell carcinoma. TFE3 is also rearranged in alveolar soft part sarcoma. To aid in diagnosis, a break-apart strategy fluorescence in situ hybridization (FISH) probe set specific for TFE3 rearrangement and a reflex dual-color, single-fusion strategy probe set involving the most common TFE3 partner gene, ASPSCR1, were validated on formalin-fixed, paraffin- embedded tissues from nine alveolar soft part sarcoma, two suspected Xp11.2 renal cell carcinoma, and nine tumors in the differential diagnosis. The impact of tissue cut artifact was reduced through inclusion of a chromosome X centromere control probe. Analysis of the UOK-109 renal carcinoma cell line confirmed the break-apart TFE3 probe set can distinguish the subtle TFE3/NONO fusion-associated inversion of chromosome X. Subsequent extensive clinical experience was gained through analysis of 75 cases with an indication of Xp11.2 renal cell carcinoma (n ¼ 54), alveolar soft part sarcoma (n ¼ 13), perivascular epithelioid cell neoplasms (n ¼ 2), chordoma (n ¼ 1), or unspecified (n ¼ 5).
  • Analyses of Allele-Specific Gene Expression in Highly Divergent

    Analyses of Allele-Specific Gene Expression in Highly Divergent

    ARTICLES Analyses of allele-specific gene expression in highly divergent mouse crosses identifies pervasive allelic imbalance James J Crowley1,10, Vasyl Zhabotynsky1,10, Wei Sun1,2,10, Shunping Huang3, Isa Kemal Pakatci3, Yunjung Kim1, Jeremy R Wang3, Andrew P Morgan1,4,5, John D Calaway1,4,5, David L Aylor1,9, Zaining Yun1, Timothy A Bell1,4,5, Ryan J Buus1,4,5, Mark E Calaway1,4,5, John P Didion1,4,5, Terry J Gooch1,4,5, Stephanie D Hansen1,4,5, Nashiya N Robinson1,4,5, Ginger D Shaw1,4,5, Jason S Spence1, Corey R Quackenbush1, Cordelia J Barrick1, Randal J Nonneman1, Kyungsu Kim2, James Xenakis2, Yuying Xie1, William Valdar1,4, Alan B Lenarcic1, Wei Wang3,9, Catherine E Welsh3, Chen-Ping Fu3, Zhaojun Zhang3, James Holt3, Zhishan Guo3, David W Threadgill6, Lisa M Tarantino7, Darla R Miller1,4,5, Fei Zou2,11, Leonard McMillan3,11, Patrick F Sullivan1,5,7,8,11 & Fernando Pardo-Manuel de Villena1,4,5,11 Complex human traits are influenced by variation in regulatory DNA through mechanisms that are not fully understood. Because regulatory elements are conserved between humans and mice, a thorough annotation of cis regulatory variants in mice could aid in further characterizing these mechanisms. Here we provide a detailed portrait of mouse gene expression across multiple tissues in a three-way diallel. Greater than 80% of mouse genes have cis regulatory variation. Effects from these variants influence complex traits and usually extend to the human ortholog. Further, we estimate that at least one in every thousand SNPs creates a cis regulatory effect.
  • Rap-3971 Alveolar Soft Part Sarcoma Chromosome

    Rap-3971 Alveolar Soft Part Sarcoma Chromosome

    DATA SHEET Alveolar Soft Part Sarcoma Chromosome Region, Candidate 1 Human Item Number rAP-3971 Synonyms ASPCR1, ASPL, ASPS, RCC17, TUG, UBXD9, UBXN9, Tether containing UBX domain for GLUT4, Alveo- lar soft part sarcoma chromosomal region candidate gene 1 protein, Alveolar soft part sarcoma locus, Re- nal papillary cell carcinoma protein 17, UBX domain-containin Description ASPSCR1 Human Recombinant produced in E. coli is a single polypeptide chain containing 576 amino acids (1-553) and having a molecular mass of 62.6kDa. ASPSCR1 is fused to a 23 amino acid His-tag at N- terminus & purified by proprietary chromatographic techniques. Uniprot Accesion Number Q9BZE9 Amino Acid Sequence MGSSHHHHHH SSGLVPRGSH MGSMAAPAGG GGSAVSVLAP NGRRHTVKVT PSTVLLQVLE DTCRRQDFNP CEYDLKFQRS VLDLSLQWRF ANLPNNAKLE MVPASRSREG PENMVRIALQ LDDGS- RLQDS FCSGQTLWEL LSHFPQIREC LQHPGGATPV CVYTRDEVTG EAALRGTTLQ SLGLTGGSAT IRFVMKCYDP VGKTPGSLGS SASAGQAAAS APLPLESGEL SRGDLSRPED ADTSGPCCEH TQEKQSTRAP AAAPFVPFSG GGQRLGGPPG PTRPLTSSSA KLPKSLSSPG GPSKPKKSKS GQDPQQEQEQ ERERDPQQEQ ERERPVDREP VDREPVVCHP DLEERLQAWP AELPDEFFEL Source Escherichia Coli. Physical Appearance Sterile Filtered clear solution. Store at 4°C if entire vial will be used within 2-4 weeks. Store, frozen at -20°C and Stability for longer periods of time. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Avoid multiple freeze-thaw cycles. Formulation and Purity The ASPSCR1 solution (0.25mg/ml) contains 20mM Tris-HCl buffer (pH 8.0), 0.15M NaCl, 10% glycerol and 1mM DTT. Greater than 85% as determined by SDS-PAGE. Application Solubility Biological Activity Shipping Format and Condition Lyophilized powder at room temperature. Optimal dilutions should be determined by each laboratory for each application.
  • Autophagy Patterns and Prognosis in Uveal Melanomas

    Autophagy Patterns and Prognosis in Uveal Melanomas

    Modern Pathology (2011) 24, 1036–1045 1036 & 2011 USCAP, Inc. All rights reserved 0893-3952/11 $32.00 Autophagy patterns and prognosis in uveal melanomas Alexandra N Giatromanolaki1, Georgios St Charitoudis2, Nikolaos E Bechrakis3, Vassilios P Kozobolis4, Michael I Koukourakis5, Michael H Foerster2 and Efthimios L Sivridis1 1Department of Pathology, Democritus University of Thrace Medical School, Alexandroupolis, Greece; 2Department of Ophthalmology, Charite´ Medical University, Campus Benjamin Franklin, Berlin, Germany; 3Department of Ophthalmology, University of Innsbruck Medical School, Innsbruck, Austria; 4Department of Ophthalmology, Democritus University of Thrace Medical School, Alexandroupolis, Greece and 5Department of Radiotherapy/Oncology, Democritus University of Thrace Medical School, Alexandroupolis, Greece Autophagy is a self-degradation mechanism by which cells recycle their own cytoplasmic constituents. It has been claimed that, under certain conditions, such a process may be associated with tumor progression. In this study, the autophagic activity was investigated in a series of 99 uveal melanomas after immunohistochemical staining for the autophagy-associated proteins MAP1LC3A and BECN1, most commonly known as LC3A and Beclin 1, respectively. These were assessed in parallel with the hypoxia-inducible factor 1a (HIF1A) and its downstream protein lactate dehydrogenase 5 (composed by five LDHA subunits). Increased autophagic reactivity, detected by MAP1LC3A or BECN1, was associated with intense pigmentation and tumor hypoxia. Uveal melanomas with extensive overexpression of BECN1 or those with underexpression of this protein were associated with the worst prognosis, but the former manifested metastases much earlier than the latter; only 58% of patients with extensive BECN1 overexpression were alive at 4 years, compared with 80% of patients with underexpressed patterns.
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus

    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
  • MBNL1 Regulates Essential Alternative RNA Splicing Patterns in MLL-Rearranged Leukemia

    MBNL1 Regulates Essential Alternative RNA Splicing Patterns in MLL-Rearranged Leukemia

    ARTICLE https://doi.org/10.1038/s41467-020-15733-8 OPEN MBNL1 regulates essential alternative RNA splicing patterns in MLL-rearranged leukemia Svetlana S. Itskovich1,9, Arun Gurunathan 2,9, Jason Clark 1, Matthew Burwinkel1, Mark Wunderlich3, Mikaela R. Berger4, Aishwarya Kulkarni5,6, Kashish Chetal6, Meenakshi Venkatasubramanian5,6, ✉ Nathan Salomonis 6,7, Ashish R. Kumar 1,7 & Lynn H. Lee 7,8 Despite growing awareness of the biologic features underlying MLL-rearranged leukemia, 1234567890():,; targeted therapies for this leukemia have remained elusive and clinical outcomes remain dismal. MBNL1, a protein involved in alternative splicing, is consistently overexpressed in MLL-rearranged leukemias. We found that MBNL1 loss significantly impairs propagation of murine and human MLL-rearranged leukemia in vitro and in vivo. Through transcriptomic profiling of our experimental systems, we show that in leukemic cells, MBNL1 regulates alternative splicing (predominantly intron exclusion) of several genes including those essential for MLL-rearranged leukemogenesis, such as DOT1L and SETD1A.Wefinally show that selective leukemic cell death is achievable with a small molecule inhibitor of MBNL1. These findings provide the basis for a new therapeutic target in MLL-rearranged leukemia and act as further validation of a burgeoning paradigm in targeted therapy, namely the disruption of cancer-specific splicing programs through the targeting of selectively essential RNA binding proteins. 1 Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA. 2 Cancer and Blood Diseases Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA. 3 Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 45229, USA.
  • Novel Insights Into Autophagy from Multicellular Model Systems

    Novel Insights Into Autophagy from Multicellular Model Systems

    Feature Review Eaten alive: novel insights into autophagy from multicellular model systems 1 2 Hong Zhang and Eric H. Baehrecke 1 Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China 2 Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA Autophagy delivers cytoplasmic material to lysosomes are essential for autophagosome formation [7,8]. Remark- for degradation. First identified in yeast, the core genes ably, the core autophagy machinery that is encoded by that control this process are conserved in higher organ- these genes is conserved between yeast and humans isms. Studies of mammalian cell cultures have expanded [6]. Many studies of immortalized mammalian cell lines our understanding of the core autophagy pathway, but indicate that, as in yeast, nutrient-limiting conditions cannot reveal the unique animal-specific mechanisms induce autophagy that is dependent on ATG genes. How- for the regulation and function of autophagy. Multicel- ever, several aspects of the autophagy pathway in higher lular organisms have different types of cells that possess eukaryotes are distinct from that in yeast. In yeast, all distinct composition, morphology, and organization of autophagosomes arise from the single perivacuolar preau- intracellular organelles. In addition, the autophagic ma- tophagosomal structure (PAS). In higher eukaryotes, there chinery integrates signals from other cells and environ- is no evidence for a PAS and isolation membranes can be mental conditions to maintain cell, tissue and organism generated simultaneously at multiple sites, implicating homeostasis. Here, we highlight how studies of autop- more complex sources for autophagosomal membranes. hagy in flies and worms have identified novel core Indeed, the endoplasmic reticulum (ER), mitochondria, autophagy genes and mechanisms, and provided insight plasma membrane, and recycling endosomes have been into the context-specific regulation and function of shown to contribute to autophagosomal membranes autophagy.
  • Multivariate Meta-Analysis of Differential Principal Components Underlying Human Primed and Naive-Like Pluripotent States

    Multivariate Meta-Analysis of Differential Principal Components Underlying Human Primed and Naive-Like Pluripotent States

    bioRxiv preprint doi: https://doi.org/10.1101/2020.10.20.347666; this version posted October 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license. October 20, 2020 To: bioRxiv Multivariate Meta-Analysis of Differential Principal Components underlying Human Primed and Naive-like Pluripotent States Kory R. Johnson1*, Barbara S. Mallon2, Yang C. Fann1, and Kevin G. Chen2*, 1Intramural IT and Bioinformatics Program, 2NIH Stem Cell Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892, USA Keywords: human pluripotent stem cells; naive pluripotency, meta-analysis, principal component analysis, t-SNE, consensus clustering *Correspondence to: Dr. Kory R. Johnson ([email protected]) Dr. Kevin G. Chen ([email protected]) 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.10.20.347666; this version posted October 21, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license. ABSTRACT The ground or naive pluripotent state of human pluripotent stem cells (hPSCs), which was initially established in mouse embryonic stem cells (mESCs), is an emerging and tentative concept. To verify this important concept in hPSCs, we performed a multivariate meta-analysis of major hPSC datasets via the combined analytic powers of percentile normalization, principal component analysis (PCA), t-distributed stochastic neighbor embedding (t-SNE), and SC3 consensus clustering.
  • Guidelines for the Use and Interpretation of Assays for Monitoring Autophagy (3Rd Edition)

    Guidelines for the Use and Interpretation of Assays for Monitoring Autophagy (3Rd Edition)

    AUTOPHAGY 2016, VOL. 12, NO. 1, 1–222 http://dx.doi.org/10.1080/15548627.2015.1100356 EDITORIAL Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) Daniel J Klionsky1745,1749*, Kotb Abdelmohsen840, Akihisa Abe1237, Md Joynal Abedin1762, Hagai Abeliovich425, Abraham Acevedo Arozena789, Hiroaki Adachi1800, Christopher M Adams1669, Peter D Adams57, Khosrow Adeli1981, Peter J Adhihetty1625, Sharon G Adler700, Galila Agam67, Rajesh Agarwal1587, Manish K Aghi1537, Maria Agnello1826, Patrizia Agostinis664, Patricia V Aguilar1960, Julio Aguirre-Ghiso784,786, Edoardo M Airoldi89,422, Slimane Ait-Si-Ali1376, Takahiko Akematsu2010, Emmanuel T Akporiaye1097, Mohamed Al-Rubeai1394, Guillermo M Albaiceta1294, Chris Albanese363, Diego Albani561, Matthew L Albert517, Jesus Aldudo128, Hana Algul€ 1164, Mehrdad Alirezaei1198, Iraide Alloza642,888, Alexandru Almasan206, Maylin Almonte-Beceril524, Emad S Alnemri1212, Covadonga Alonso544, Nihal Altan-Bonnet848, Dario C Altieri1205, Silvia Alvarez1497, Lydia Alvarez-Erviti1395, Sandro Alves107, Giuseppina Amadoro860, Atsuo Amano930, Consuelo Amantini1554, Santiago Ambrosio1458, Ivano Amelio756, Amal O Amer918, Mohamed Amessou2089, Angelika Amon726, Zhenyi An1538, Frank A Anania291, Stig U Andersen6, Usha P Andley2079, Catherine K Andreadi1690, Nathalie Andrieu-Abadie502, Alberto Anel2027, David K Ann58, Shailendra Anoopkumar-Dukie388, Manuela Antonioli832,858, Hiroshi Aoki1791, Nadezda Apostolova2007, Saveria Aquila1500, Katia Aquilano1876, Koichi Araki292, Eli Arama2098,
  • Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights Into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle

    Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights Into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle

    animals Article Integrating Single-Step GWAS and Bipartite Networks Reconstruction Provides Novel Insights into Yearling Weight and Carcass Traits in Hanwoo Beef Cattle Masoumeh Naserkheil 1 , Abolfazl Bahrami 1 , Deukhwan Lee 2,* and Hossein Mehrban 3 1 Department of Animal Science, University College of Agriculture and Natural Resources, University of Tehran, Karaj 77871-31587, Iran; [email protected] (M.N.); [email protected] (A.B.) 2 Department of Animal Life and Environment Sciences, Hankyong National University, Jungang-ro 327, Anseong-si, Gyeonggi-do 17579, Korea 3 Department of Animal Science, Shahrekord University, Shahrekord 88186-34141, Iran; [email protected] * Correspondence: [email protected]; Tel.: +82-31-670-5091 Received: 25 August 2020; Accepted: 6 October 2020; Published: 9 October 2020 Simple Summary: Hanwoo is an indigenous cattle breed in Korea and popular for meat production owing to its rapid growth and high-quality meat. Its yearling weight and carcass traits (backfat thickness, carcass weight, eye muscle area, and marbling score) are economically important for the selection of young and proven bulls. In recent decades, the advent of high throughput genotyping technologies has made it possible to perform genome-wide association studies (GWAS) for the detection of genomic regions associated with traits of economic interest in different species. In this study, we conducted a weighted single-step genome-wide association study which combines all genotypes, phenotypes and pedigree data in one step (ssGBLUP). It allows for the use of all SNPs simultaneously along with all phenotypes from genotyped and ungenotyped animals. Our results revealed 33 relevant genomic regions related to the traits of interest.
  • MAP1LC3 Antibody Cat

    MAP1LC3 Antibody Cat

    MAP1LC3 Antibody Cat. No.: 7951 MAP1LC3 Antibody Immunohistochemistry of MAP1LC3 in rat brain tissue with MAP1LC3 antibody at 5 μg/ml. Specifications HOST SPECIES: Rabbit SPECIES REACTIVITY: Human, Mouse, Rat HOMOLOGY: Predicted species reactivity based on immunogen sequence: Bovine: (100%) MAP1LC3 antibody was raised against a 12 amino acid peptide near the center of human MAP1LC3A. IMMUNOGEN: The immunogen is located within amino acids 20 - 70 of MAP1LC3. TESTED APPLICATIONS: ELISA, IHC-P, WB September 29, 2021 1 https://www.prosci-inc.com/map1lc3-antibody-7951.html MAP1LC3 antibody can be used for detection of MAP1LC3 by Western blot at 0.5 - 1 μg/ml. Antibody can also be used for Immunohistochemistry starting at 5 μg/mL. APPLICATIONS: Antibody validated: Western Blot in human samples and Immunohistochemistry in rat samples. All other applications and species not yet tested. MAP1LC3 antibody is human, mouse and rat reactive. Multiple isoforms MAP1LC3 are SPECIFICITY: known to exist. MAP1LC3 antibody is predicted to detect MAP1LC3A, MAP1LC3B, and MAP1LC3C. POSITIVE CONTROL: 1) Cat. No. 1303 - Human Brain Tissue Lysate Predicted: 13 kDa PREDICTED MOLECULAR WEIGHT: Observed: 18 kDa Properties PURIFICATION: MAP1LC3 antibody is affinity chromatography purified via peptide column. CLONALITY: Polyclonal ISOTYPE: IgG CONJUGATE: Unconjugated PHYSICAL STATE: Liquid BUFFER: MAP1LC3 antibody is supplied in PBS containing 0.02% sodium azide. CONCENTRATION: 1 mg/mL MAP1LC3 antibody can be stored at 4˚C for three months and -20˚C, stable for up to one STORAGE CONDITIONS: year. Additional Info OFFICIAL SYMBOL: MAP1LC3A MAP1LC3 Antibody: LC3, LC3A, ATG8E, MAP1ALC3, MAP1BLC3Autophagy-related protein ALTERNATE NAMES: LC3 A ACCESSION NO.: NP_115903 PROTEIN GI NO.: 14210522 GENE ID: 84557 USER NOTE: Optimal dilutions for each application to be determined by the researcher.
  • Research Article Deletion of Herpud1 Enhances Heme Oxygenase-1 Expression in a Mouse Model of Parkinson's Disease

    Research Article Deletion of Herpud1 Enhances Heme Oxygenase-1 Expression in a Mouse Model of Parkinson's Disease

    Hindawi Publishing Corporation Parkinson’s Disease Volume 2016, Article ID 6163934, 9 pages http://dx.doi.org/10.1155/2016/6163934 Research Article Deletion of Herpud1 Enhances Heme Oxygenase-1 Expression in a Mouse Model of Parkinson’s Disease Thuong Manh Le,1 Koji Hashida,1 Hieu Minh Ta,1 Mika Takarada-Iemata,1,2 Koichi Kokame,3 Yasuko Kitao,1,2 and Osamu Hori1,2 1 Department of Neuroanatomy, Kanazawa University Graduate School of Medical Science, Kanazawa, Ishikawa 920-8640, Japan 2CREST, JST (Japan Science and Technology), Tokyo 102-8666, Japan 3Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center, Osaka 565-8565, Japan Correspondence should be addressed to Osamu Hori; [email protected] Received 21 November 2015; Revised 25 January 2016; Accepted 28 January 2016 Academic Editor: Antonio Pisani Copyright © 2016 Thuong Manh Le et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Herp is an endoplasmic reticulum- (ER-) resident membrane protein that plays a role in ER-associated degradation. We studied the expression of Herp and its effect on neurodegeneration in a mouse model of Parkinson’s disease (PD), in which both the oxidative stress and the ER stress are evoked. Eight hours after administering a PD-related neurotoxin, 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP), to mice, the expression of Herp increased at both the mRNA and the protein levels. Experiments using +/+ −/− Herpud1 and Herpud1 mice revealed that the status of acute degeneration of nigrostriatal neurons and reactive astrogliosis was comparable between two genotypes after MPTP injection.